# TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tp53-mutations-predict-for-poor-survival-in-alk-rearrangement-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wenxian Wang,C. Xu,Yanping Chen,Wei Liu,Lihua Zhong,Fangfang Chen,Wu Zhuang,Yunjian Huang,Zhangzhou Huang,Rongrong Chen,Yanfang Guan,Xin Yi,Tang-Feng Lv,Weifeng Zhu,Jianping Lu,Xiaojiang Wang,Yi Shi,Xiandong Lin,Gang Chen,Yong Song |
| Citations | 69 |
| DOI | 10.21037/jtd.2018.04.98 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://jtd.amegroups.com/article/viewFile/21240/pdf |
| OpenAlex ID | https://openalex.org/W2803878660 |
| PMID | 29997966 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Wenxian Wang](https://scholariq.org/researchers/wenxian-wang/)
- [C. Xu](https://scholariq.org/researchers/c-xu/)

## Paper journal

- [Journal of Thoracic Disease](https://scholariq.org/journals/journal-of-thoracic-disease/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.